Disrupted White Matter Microstructure in Newborns with Antenatal Opioid Exposure

Maria G.. Mora Alvarez, Children's National Hospital, Washington, DC, United States; Josepheen De Asis-Cruz, Children's National Health System, Washington DC, DC, United States; Kushal Kapse, Children's National Health System, Washington, DC, United States; Yao Wu, Children's National Hospital, Washington, DC, United States; Stephanie L. Merhar, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, United States; Carla Bann, RTI International, Apex, NC, United States; Jamie E. Newman, RTI International, Carrboro, NC, United States; Nicole Mack, RTI International, Chicago, IL, United States; Sara B.. DeMauro, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, United States; Namasivayam Ambalavanan, University of Alabama School of Medicine, Birmingham, AL, United States; Scott A. Lorch, The Children's Hospital of Philadelphia, Philadelphia, PA, United States; Deanne Wilson-Costello, Case Western Reserve University School of Medicine, Cleveland, OH, United States; Brenda Poindexter, Children's Healthcare of Atlanta, Atlanta, GA, United States; Myriam Peralta-Carcelen, University of Alabama at Birmingham, School of Medicine, Birmingham, AL, United States; Jonathan Davis, Tufts Medical Center, Boston, MA, United States; Catherine Limperopoulos, Children's National Health System, Washington DC, DC, United States